Implementing pre-procedural thrombopoietin receptor agonists in cirrhotic patients with severe thrombocytopenia: Indiscriminate, selective or unneeded?

Primignani, M; Tosetti, G; Tripodi, A

Primignani, M; Tosetti, G; Tripodi, A.

Affiliation

Primignani M; Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology, Milan, Italy. Electronic address: massimo.primignani@policlinico.mi.it.
Tosetti G; Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology, Milan, Italy.
Tripodi A; Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milano, Italy.

Dig Liver Dis ; 53(11): 1394-1395, 2021 11.

Article in En | MEDLINE | ID: mdl-34446353

Subject(s)

Leukopenia; Thrombocytopenia; Humans; Liver Cirrhosis/complications; Platelet Count; Receptors, Thrombopoietin; Thrombocytopenia/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Leukopenia Limits: Humans Language: En Journal: Dig Liver Dis Journal subject: GASTROENTEROLOGIA Year: 2021 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google